Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2009 | 1 |
2010 | 1 |
2014 | 1 |
2015 | 2 |
2016 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine.
Int Rev Immunol. 2009;28(1):49-68. doi: 10.1080/08830180802495605.
Int Rev Immunol. 2009.
PMID: 19241253
Free PMC article.
Review.
Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins.
Sealy RE, Jones BG, Surman SL, Branum K, Howlett NM, Flynn PM, Hurwitz JL.
Sealy RE, et al. Among authors: howlett nm.
Viral Immunol. 2016 Jan-Feb;29(1):64-70. doi: 10.1089/vim.2015.0078. Epub 2015 Nov 6.
Viral Immunol. 2016.
PMID: 26544795
Free PMC article.
Item in Clipboard
Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials.
Brown SA, Surman SL, Sealy R, Jones BG, Slobod KS, Branum K, Lockey TD, Howlett N, Freiden P, Flynn P, Hurwitz JL.
Brown SA, et al. Among authors: howlett n.
Viruses. 2010 Feb 1;2(2):435-467. doi: 10.3390/v2020435.
Viruses. 2010.
PMID: 20407589
Free PMC article.
Item in Clipboard
First phase I clinical trial of an HIV-1 subtype D gp140 envelope protein vaccine: immune activity induced in all study participants.
Hurwitz JL, Lockey TD, Jones B, Freiden P, Sealy R, Coleman J, Howlett N, Branum K, Slobod KS.
Hurwitz JL, et al. Among authors: howlett n.
AIDS. 2008 Jan 2;22(1):149-51. doi: 10.1097/QAD.0b013e3282f174ed.
AIDS. 2008.
PMID: 18090404
Clinical Trial.
Item in Clipboard
Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children.
Adderson E, Branum K, Sealy RE, Jones BG, Surman SL, Penkert R, Freiden P, Slobod KS, Gaur AH, Hayden RT, Allison K, Howlett N, Utech J, Allay J, Knight J, Sleep S, Meagher MM, Russell CJ, Portner A, Hurwitz JL.
Adderson E, et al. Among authors: howlett n.
Clin Vaccine Immunol. 2015 Mar;22(3):298-303. doi: 10.1128/CVI.00618-14. Epub 2014 Dec 31.
Clin Vaccine Immunol. 2015.
PMID: 25552633
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite